Novo Nordisk Parent Resubmits Catalent Deal Application to FTC

Novo Nordisk Parent Resubmits Catalent Deal Application to FTC

Novo Nordisk’s parent company, Novo Nordisk Foundation, has refiled its application to the U.S. Federal Trade Commission (FTC) seeking approval…

Read More »